{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:13:14Z","timestamp":1790701994852,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1093\/jac\/dkw466","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T10:19:40Z","timestamp":1476181180000},"page":"376-384","source":"Crossref","is-referenced-by-count":140,"title":["Intrinsic rifamycin resistance of\n                    <i>Mycobacterium abscessus<\/i>\n                    is mediated by ADP-ribosyltransferase MAB_0591"],"prefix":"10.1093","volume":"72","author":[{"given":"Anna","family":"Rominski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Roditscheff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Selchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik C.","family":"B\u00f6ttger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"2017012307351438000_72.2.376.1","doi-asserted-by":"publisher","DOI":"10.1086\/504381"},{"key":"2017012307351438000_72.2.376.2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.4.716-746.2002"},{"key":"2017012307351438000_72.2.376.3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2017012307351438000_72.2.376.4","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/147.5.1271"},{"key":"2017012307351438000_72.2.376.5","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.37.20905"},{"key":"2017012307351438000_72.2.376.6","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.2.816-819.2001"},{"key":"2017012307351438000_72.2.376.7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05030-11"},{"key":"2017012307351438000_72.2.376.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(00)90024-7"},{"key":"2017012307351438000_72.2.376.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000313974","article-title":"Mycobacterium abscessus skin infection after tattooing: first case report and review of the literature","volume":"221","author":"Bechara","year":"2010","journal-title":"Dermatology"},{"key":"2017012307351438000_72.2.376.10","doi-asserted-by":"publisher","DOI":"10.1086\/320885"},{"key":"2017012307351438000_72.2.376.11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr578"},{"key":"2017012307351438000_72.2.376.12","first-page":"262","article-title":"Rifomycin. I. Isolation and properties of rifomycin B and rifomycin complex","volume":"7","author":"Sensi","year":"1960","journal-title":"Antibiot Annu"},{"key":"2017012307351438000_72.2.376.13","first-page":"11","article-title":"Rifampin\u2013new and potent drug for TB treatment","volume":"57","author":"Fisher","year":"1971","journal-title":"Bull Natl Tuberc Respir Dis Assoc"},{"key":"2017012307351438000_72.2.376.14","unstructured":"Wehrli W Handschin J Wunderli W. Interaction between rifampicin and DNA-dependent RNA polymerase of E. coli. In: Losick R Chamberlin M , eds. RNA Polymerase. New York: Cold Spring Harbor Laboratory Press, 1976; 397\u2013412."},{"key":"2017012307351438000_72.2.376.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00286-0"},{"key":"2017012307351438000_72.2.376.16","doi-asserted-by":"publisher","DOI":"10.1038\/220276a0"},{"key":"2017012307351438000_72.2.376.17","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(69)80305-4"},{"key":"2017012307351438000_72.2.376.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.syapm.2005.02.009"},{"key":"2017012307351438000_72.2.376.19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/AAC.40.3.646","article-title":"Rifampin resistance in Neisseria meningitides due to alterations in membrane permeability","volume":"40","author":"Abadi","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"2017012307351438000_72.2.376.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1996.tb03303.x"},{"key":"2017012307351438000_72.2.376.21","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/33.6.1127"},{"key":"2017012307351438000_72.2.376.22","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1128\/AAC.41.11.2456","article-title":"Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic","volume":"41","author":"Quan","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2017012307351438000_72.2.376.23","first-page":"169","article-title":"Partial purification and characterization of ADP-ribosyltransferase produced by Legionella pneumophila","volume":"2","author":"Belyi","year":"1991","journal-title":"Biomed Sci"},{"key":"2017012307351438000_72.2.376.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2009.12.017"},{"key":"2017012307351438000_72.2.376.25","doi-asserted-by":"publisher","DOI":"10.1007\/BF00330662"},{"key":"2017012307351438000_72.2.376.26","first-page":"127","article-title":"Nucleotide substitutions in the rpoB gene leading to rifampicin resistance of E. coli RNA polymerase","volume":"10","author":"Lisitsyn","year":"1984","journal-title":"Bioorg Khim"},{"key":"2017012307351438000_72.2.376.27","doi-asserted-by":"publisher","DOI":"10.1007\/BF00334112"},{"key":"2017012307351438000_72.2.376.28","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(88)90517-7"},{"key":"2017012307351438000_72.2.376.29","doi-asserted-by":"crossref","first-page":"14820","DOI":"10.1016\/S0021-9258(18)82407-3","article-title":"New rifampicin-resistant and streptolydigin-resistant mutants in the \u03b2 subunit of Escherichia coli RNA polymerase","volume":"268","author":"Severinov","year":"1993","journal-title":"J Biol Chem"},{"key":"2017012307351438000_72.2.376.30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00283512","article-title":"RifR mutations in the beginning of the Escherichia coli rpoB gene","volume":"244","author":"Severinov","year":"1994","journal-title":"Mol Gen Genet"},{"key":"2017012307351438000_72.2.376.31","doi-asserted-by":"publisher","DOI":"10.1054\/tuld.1998.0002"},{"key":"2017012307351438000_72.2.376.32","unstructured":"Zhang Y Telenti A. Genetics of drug resistance in Mycobacterium tuberculosis . In: Hatfull GF Jacobs WR Jr , eds. Molecular Genetics of Mycobacteria. Washington, DC: ASM Press, 2000; 235\u201354."},{"key":"2017012307351438000_72.2.376.33","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.17"},{"key":"2017012307351438000_72.2.376.34","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90417-F"},{"key":"2017012307351438000_72.2.376.35","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/AAC.39.9.2164","article-title":"Sequence and analysis of the rpoB gene of Mycobacterium smegmatis","volume":"39","author":"Hetherington","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2017012307351438000_72.2.376.36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/AAC.43.1.181","article-title":"ADP-ribosylation as an intermediate step in inactivation of rifampin by a mycobacterial gene","volume":"43","author":"Quan","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2017012307351438000_72.2.376.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2006.10.016"},{"key":"2017012307351438000_72.2.376.38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005660"},{"key":"2017012307351438000_72.2.376.39","doi-asserted-by":"publisher","DOI":"10.1021\/bi200178z"},{"key":"2017012307351438000_72.2.376.40","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.6.3562-3568.2001"},{"key":"2017012307351438000_72.2.376.41","unstructured":"Siddiqui S. BACTEC TB System. Product and Procedure Manual. Sparks, MD: Becton Dickinson, 1996."},{"key":"2017012307351438000_72.2.376.42","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02501-08"},{"key":"2017012307351438000_72.2.376.43","doi-asserted-by":"publisher","DOI":"10.1016\/S1438-4221(01)80004-7"},{"key":"2017012307351438000_72.2.376.44","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05649-11"},{"key":"2017012307351438000_72.2.376.45","unstructured":"Clinical and Laboratory Standards Institute. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes\u2014Second Edition: Approved Standard M24-A2. CLSI, Wayne, PA, USA, 2011."},{"key":"2017012307351438000_72.2.376.46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084065"},{"issue":"Suppl 3","key":"2017012307351438000_72.2.376.47","doi-asserted-by":"crossref","first-page":"S606","DOI":"10.1093\/clinids\/5.Supplement_3.S606","article-title":"Rifampin in the treatment of leprosy","volume":"5","author":"Bullock","year":"1983","journal-title":"Rev Infect Dis"},{"key":"2017012307351438000_72.2.376.48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711939105"},{"key":"2017012307351438000_72.2.376.49","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fmicb.2015.00963","article-title":"Pseudomonas exotoxin A: optimized by evolution for effective killing","volume":"6","author":"Michalska","year":"2015","journal-title":"Front Microbiol"},{"key":"2017012307351438000_72.2.376.50","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1128\/JCM.24.6.976-981.1986","article-title":"Susceptibility testing of slow growing mycobacteria by a microdilution MIC method with 7H9 broth","volume":"24","author":"Wallace","year":"1986","journal-title":"J Clin Microbiol"},{"key":"2017012307351438000_72.2.376.51","doi-asserted-by":"publisher","DOI":"10.1111\/mmi.12387"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/2\/376\/9684151\/dkw466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T23:25:04Z","timestamp":1657409104000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,1,23]]},"published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1093\/jac\/dkw466"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw466","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]}}}